0

customer partnerships

0

FISH, NGS and array products developed

0

countries where are products are used

0

years' experience in molecular genetics

Explore our products

CytoCell
FISH

World-leading FISH solutions

Discover more
SureSeq
NGS

Innovative NGS technology

Discover more
CytoSure
Arrays

Uncompromising quality

Discover more

Precision medicine partnering

Accelerate your clinical trial assay and CDx development programs in hematological malignancies by partnering with OGT’s precision medicine team

Discover more

Latest OGT news

View all OGT News
OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel Image

OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel

22 Jan 2025

Ultra-low variant detection (including very large FLT3-ITDs) enables a stronger characterization of a sample’s current AML status.

Read
OGT unveils the enhanced SureSeq CLL + CNV V3 Panel for deeper insights into CLL progression Image

OGT unveils the enhanced SureSeq CLL + CNV V3 Panel for deeper insights into CLL progression

02 Dec 2024

Improving upon existing SureSeq™ technology, this latest SureSeq NGS panel unlocks more efficient and expansive genetic profiling for CLL samples

Read
OGT launches new SureSeq Myeloid Fusion Panel to help drive advances in myeloid cancer research   Image

OGT launches new SureSeq Myeloid Fusion Panel to help drive advances in myeloid cancer research

30 Apr 2024

Enables users to replace multiple techniques with a single streamlined NGS process for faster results.

Read
CTA Icon

Stay up-to-date with the latest news from OGT, including new products, support resources, and our DNA Dispatch newsletter